Aethlon Medical Inc.
Lantheus Medical Imaging Inc. finance chief Jeffrey Young resigned from his post, effective August 9. The CFO’s shoes will be filled by interim finance chief John Golubieski, formerly the CFO of Fougera Pharmaceuticals and finance VP at King Pharmaceuticals.
J&J has been doing business in China for more than 25 years, including last year’s launch of a medical device and diagnostics innovation center there.
Covidien (NYSE:COV) named Stacy Enxing Seng president of its $1.4 billion global vascular therapies business.
Enxing Seng, 47, will lead the division’s 4,000 employees, reporting to Peter Wehrly, president of the Mansfield, Mass.-based firm’s respiratory & monitoring solutions and vascular therapies division. She joined Covidien in July 2010 after the company spent $2.6 billion acquiring ev3 and its Pipeline embolization treatment for cerebral aneurysms.